RTW INVESTMENTS, LP - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 63 filers reported holding PROQR THRAPEUTICS N V in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q1 2022$6,354,000
-88.7%
7,019,610
-0.1%
0.13%
-83.9%
Q4 2021$56,292,000
+4.4%
7,027,725
+9.1%
0.82%
+1.1%
Q3 2021$53,929,000
+24.2%
6,443,1130.0%0.81%
+24.1%
Q2 2021$43,427,000
+2.3%
6,443,113
+0.3%
0.66%
-1.2%
Q1 2021$42,463,000
+101.8%
6,424,078
+28.2%
0.66%
+87.8%
Q4 2020$21,041,000
-11.7%
5,009,768
+0.7%
0.35%
-38.5%
Q3 2020$23,822,000
-20.1%
4,973,174
+1.4%
0.57%
-31.6%
Q2 2020$29,809,000
+13.6%
4,902,785
+2.6%
0.84%
-25.7%
Q1 2020$26,237,000
-44.6%
4,779,1350.0%1.13%
-36.8%
Q4 2019$47,361,000
+122.2%
4,779,135
+29.1%
1.79%
+40.9%
Q3 2019$21,317,000
-37.1%
3,700,833
-0.6%
1.27%
-29.9%
Q2 2019$33,879,000
-34.4%
3,722,9500.0%1.81%
-48.7%
Q1 2019$51,637,000
+630.2%
3,722,950
+730.8%
3.52%
+435.7%
Q4 2018$7,072,000
-90.2%
448,141
-88.0%
0.66%
-84.8%
Q3 2018$72,358,0003,739,4064.33%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q1 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,237,400$5,197,0001.55%
Prosight Management, LP 255,000$1,071,0000.50%
RTW INVESTMENTS, LP 5,009,768$21,041,0000.35%
Kerrisdale Advisers, LLC 453,182$1,903,0000.15%
Artal Group S.A. 1,196,218$5,024,0000.11%
COWEN AND COMPANY, LLC 285,696$1,200,0000.11%
Golden Green, Inc. 16,999$71,0000.07%
APOGEM CAPITAL LLC 15,855$67,0000.04%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$19,110,0000.04%
ALTRINSIC GLOBAL ADVISORS LLC 241,360$1,014,0000.03%
View complete list of PROQR THRAPEUTICS N V shareholders